NCT06710756 2026-01-16Lead-212 PSV359 Therapy for Patients With Solid TumorsPerspective TherapeuticsPhase 1/2 Recruiting112 enrolled
NCT05544929 2026-01-06A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersNovartisPhase 1 Active not recruiting126 enrolled
NCT03556228 2025-12-11VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLCPhase 1/2 Recruiting242 enrolled
NCT06336148 2025-10-15A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsActym Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT02903914 2025-08-05Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsIncyte CorporationPhase 1 Completed260 enrolled 52 charts
NCT05944237 2025-06-08HTL0039732 in Participants With Advanced Solid TumoursCancer Research UKPhase 1/2 Recruiting150 enrolled